About Wheeler Bio
Wheeler Bio is a company based in Oklahoma City (United States) founded in 2020 by Jesse McCool. Wheeler Bio has raised $103.15 million across 5 funding rounds from investors including Charles River Laboratories, Alloy Therapeutics and Mitsubishi Corporation. Wheeler Bio offers products and services including Modular CMC Services, Cell Line Development, and Process Development. Wheeler Bio operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.
- Headquarter Oklahoma City, United States
- Founders Jesse McCool
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$103.15 M (USD)
in 5 rounds
-
Latest Funding Round
$35 M (USD), Series A
Mar 04, 2025
-
Investors
Charles River Laboratories
& 14 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Wheeler Bio
Wheeler Bio offers a comprehensive portfolio of products and services, including Modular CMC Services, Cell Line Development, and Process Development.
Accelerates biologics from discovery to clinical supply with efficient processes.
Creates stable cell lines for protein expression and preclinical testing.
Optimizes manufacturing processes for biologics production and characterization.
People of Wheeler Bio
Unlock access to complete
Funding Insights of Wheeler Bio
Wheeler Bio has successfully raised a total of $103.15M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $35 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Wheeler Bio
Wheeler Bio has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include Charles River Laboratories, Alloy Therapeutics and Mitsubishi Corporation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Echo Investment Capital is engaged in multi-strategy investment management.
|
Locked | Locked | Locked | |
|
Venture capital investments are focused on FoodTech and AgTech sectors.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on tech companies
|
Locked | Locked | Locked |
Investor details for Wheeler Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Wheeler Bio
Investment portfolio details for Wheeler Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Wheeler Bio
Detailed financials for Wheeler Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wheeler Bio Comparisons
Peer comparison for Wheeler Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Wheeler Bio
Wheeler Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| Locked | Locked | Locked |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| Locked | Locked | Locked |
CDMO and analytical services for peptide development are provided.
|
|
| Locked | Locked | Locked |
APIs and finished dosage forms are developed and manufactured.
|
Detailed competitors of Wheeler Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wheeler Bio
Complete news archive for Wheeler Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wheeler Bio
Wheeler Bio was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Wheeler Bio is headquartered in Oklahoma City, United States. It is registered at Oklahoma City, Oklahoma, United States.
Jesse McCool is the current CEO of Wheeler Bio. They have also founded this company.
Wheeler Bio is a funded company, having raised a total of $103.15M across 5 funding rounds to date.
Wheeler Bio was founded in 2020 and is headquartered in Oklahoma City, United States. Services in drug research and analytical development are offered by the company across various therapeutic areas within the biotechnology sector. Operations emphasize support for pharmaceutical innovation, including process optimization and quality assurance. Leadership is provided by co-founder and CEO Jesse McCool, with a focus on reliable, data-driven solutions for clients in the life sciences industry.
Wheeler Bio's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
Wheeler Bio offers Modular CMC Services, Cell Line Development, and Process Development.
Wheeler Bio has 15 investors. Key investors include Charles River Laboratories, Alloy Therapeutics, Mitsubishi Corporation, Echo Investment, and Atum.